Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Purinergic signaling and vascular cell proliferation and death Burnstock GArterioscler Thromb Vasc Biol 2002[Mar]; 22 (3): 364-73Evidence for the role of purinergic signaling (via P1 and P2Y receptors) in the proliferation of vascular smooth muscle and endothelial cells is reviewed. The involvement of the mitogen-activated protein kinase second-messenger cascade in this action is clearly implicated, although details of the precise intracellular pathways involved still remain to be determined. Synergistic actions of purines and pyrimidines with growth factors occur in promoting cell proliferation. Interaction between purinergic signaling for vascular cell proliferation and cell death mediated by P2X7 receptors is discussed. There is evidence of the release of ATP from endothelial cells, platelets, and sympathetic nerves as well as from damaged cells in atherosclerosis, hypertension, restenosis, and ischemia; furthermore, there is evidence that vascular smooth muscle and endothelial cells proliferate in these pathological conditions. Thus, the involvement of ATP and its breakdown product, adenosine, is implicated; it is hoped that with the development of selective P1 (A2) and P2Y receptor agonists and antagonists, new therapeutic strategies will be explored.|Adenosine Diphosphate/physiology[MESH]|Adenosine Triphosphate/physiology[MESH]|Adenosine/physiology[MESH]|Animals[MESH]|Apoptosis[MESH]|Cell Division[MESH]|Endothelium, Vascular/*metabolism[MESH]|Humans[MESH]|MAP Kinase Signaling System[MESH]|Muscle, Smooth, Vascular/*metabolism[MESH]|Receptors, Purinergic P1/*physiology[MESH]|Receptors, Purinergic P2/*physiology[MESH]|Uridine Triphosphate/physiology[MESH]|Vascular Diseases/etiology[MESH] |
